In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

PURPOSE: Colistin is a drug of last resort for treating multidrug-resistant Acinetobacter baumannii infections. Unfortunately, colistin-resistant A. baumannii (CoR-AB) has been reported. Here, we examined the in vitro effect of mono- and combined antimicrobials against CoR-AB strains and their resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lertsrisatit, Yongyut, Santimaleeworagun, Wichai, Thunyaharn, Sudaluck, Traipattanakul, Jantima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700765/
https://www.ncbi.nlm.nih.gov/pubmed/29200878
http://dx.doi.org/10.2147/IDR.S148185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700765/
https://www.ncbi.nlm.nih.gov/pubmed/29200878
http://dx.doi.org/10.2147/IDR.S148185

Ejemplares similares